The firestorm surrounding the spiraling price of Mylan’s EpiPen is fueling interest in lower-cost alternatives to the emergency allergy treatment, including a lesser-known but similar auto-injector that has been on the market since 2013.
The firestorm surrounding the spiraling price of Mylan’s EpiPen is fueling interest in lower-cost alternatives to the emergency allergy treatment, including a lesser-known but similar auto-injector that has been on the market since 2013.
Links
[1] http://www.post-gazette.com/business/healthcare-business/2016/09/07/Consumers-seek-alternatives-to-EpiPen/stories/201609070057
